“En You is an outstanding director of internal controls at Calix. He helped our IT department build, and sustain several change and logical access controls for our financial systems. He provided critical guidance during several external audits to help ease the workload. He is always available to handle emergency situations when they arise, and he doesn't mind rolling up his sleeves to help out with whatever task is needed at the moment. I highly recommend En You for any company that needs a highly skilled, very easy to talk to, goal oriented Compliance director. ”
Activity
-
In commemoration of the three-day Chinese #DragonBoatFestival celebration, the team at our Shanghai office hosted a series of activities true to…
In commemoration of the three-day Chinese #DragonBoatFestival celebration, the team at our Shanghai office hosted a series of activities true to…
Liked by En You Thong
-
Finished the Anchorage Half Marathon this morning with our son, Noah. A beautiful course largely through the woods and along the bay. I shaved more…
Finished the Anchorage Half Marathon this morning with our son, Noah. A beautiful course largely through the woods and along the bay. I shaved more…
Liked by En You Thong
-
That's a wrap for #ADA2024! Our team enjoyed showcasing data from our Phase 1b/2a study of GSBR-1290, a #smallmolecule #GLP1 receptor agonist in…
That's a wrap for #ADA2024! Our team enjoyed showcasing data from our Phase 1b/2a study of GSBR-1290, a #smallmolecule #GLP1 receptor agonist in…
Liked by En You Thong
Recommendations received
1 person has recommended En You
Join now to viewMore activity by En You
-
Our CEO Raymond Stevens recently spoke with CNBC Fast Money's Melissa Lee to discuss our progress with our #GLP1 receptor agonist drug, GSBR-1290…
Our CEO Raymond Stevens recently spoke with CNBC Fast Money's Melissa Lee to discuss our progress with our #GLP1 receptor agonist drug, GSBR-1290…
Liked by En You Thong
-
We're pleased to share positive topline data from our 12-week Phase 2a #obesity study of our oral, non-peptide GLP-1 receptor agonist, GSBR-1290…
We're pleased to share positive topline data from our 12-week Phase 2a #obesity study of our oral, non-peptide GLP-1 receptor agonist, GSBR-1290…
Liked by En You Thong
-
Dive into the future of biotech with Clora's CEO Rahul Chaturvedi as they explore entrepreneurship, hiring talent with an eye towards building a…
Dive into the future of biotech with Clora's CEO Rahul Chaturvedi as they explore entrepreneurship, hiring talent with an eye towards building a…
Liked by En You Thong
-
This week, we are joined by Raymond Stevens, CEO of Structure Therapeutics. Ray joins host Rahul Chaturvedi as they discuss the arc of his career…
This week, we are joined by Raymond Stevens, CEO of Structure Therapeutics. Ray joins host Rahul Chaturvedi as they discuss the arc of his career…
Liked by En You Thong
-
Today, we reported program updates and financial results for the fourth quarter and year ended December 31, 2023. Read the full press release here:…
Today, we reported program updates and financial results for the fourth quarter and year ended December 31, 2023. Read the full press release here:…
Liked by En You Thong
-
Thank you to the Singapore Consulate-General in SF and Singapore Global Network for organizing this event with PM Lee. Great Singapore food and catch…
Thank you to the Singapore Consulate-General in SF and Singapore Global Network for organizing this event with PM Lee. Great Singapore food and catch…
Liked by En You Thong
People also viewed
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More